Furthermore, the mRNA expression of OGR1 correlates with clinical scores given to IBD patients, indicating that OGR1 has a clinically relevant pro-inflammatory effect that could constitute a therapeutic target [22,23]. Here, GPR68 is linked to inflammatory bowel disease.